Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

NBPF24 Inhibitors

NBPF24 inhibitors represent a theoretical category of chemical entities intended to selectively interfere with the activity of the NBPF24 protein. NBPF24 is part of the Neuroblastoma BreakPoint Family, a group of proteins that have been associated with neurodevelopmental processes and are characterized by their diverse and complex genomic arrangements. While the specific functions of many NBPF proteins, including NBPF24, have not been fully delineated, the family is generally believed to be involved in the regulation of neuronal development and associated cellular mechanisms. The development of inhibitors targeting NBPF24 would require precise design to ensure that the inhibition is specific to NBPF24 and does not inadvertently affect the function of other members of the NBPF family or unrelated proteins due to sequence or functional similarities.

The creation of NBPF24 inhibitors would be predicated on a deep molecular understanding of NBPF24, including its domain structure, active sites, and interaction partners. This would likely involve the use of high-resolution techniques such as cryo-electron microscopy or X-ray crystallography to obtain a detailed three-dimensional structure of the protein. Such structural insights would be vital for identifying potential druggable sites where small molecules could bind to modulate the protein's function. Additionally, computational modeling and virtual screening could be leveraged to predict the interaction of candidate molecules with these sites, guiding the synthesis of compounds that could act as NBPF24 inhibitors. Through a combination of empirical data and in silico analysis, initial candidates for NBPF24 inhibition would be identified and synthesized for further testing.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound is a DNA methyltransferase inhibitor that can cause hypomethylation of DNA, potentially altering gene expression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Similar to 5-azacytidine, decitabine can lead to DNA hypomethylation and could disrupt the expression of various genes.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Vorinostat is a histone deacetylase inhibitor that causes hyperacetylation of histones, potentially changing chromatin structure and gene expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A is another histone deacetylase inhibitor that may result in altered gene expression through changes in chromatin accessibility.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium butyrate serves as a histone deacetylase inhibitor, potentially affecting gene expression by altering histone modification.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

Entinostat is a selective histone deacetylase inhibitor that could modulate gene expression profiles.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$218.00
$634.00
1
(1)

Romidepsin is a histone deacetylase inhibitor that may change gene expression patterns, including potentially those of NBPF11.

Panobinostat

404950-80-7sc-208148
10 mg
$200.00
9
(1)

Panobinostat is a potent histone deacetylase inhibitor that could influence expression of a wide range of genes.

Temozolomide

85622-93-1sc-203292
sc-203292A
25 mg
100 mg
$91.00
$255.00
32
(1)

Temozolomide methylates DNA, which can lead to mispairing or breaks in DNA strands, affecting transcription and potentially gene expression.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

Valproic acid has histone deacetylase inhibitory activity, which might alter epigenetic regulation of gene expression, including NBPF11.